Mednax Reports Fourth Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Stocks fall as higher oil prices, Treasury yields weigh
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
MEDNAX (MD) Tops Q4 EPS by 8c; Issues 2022 EBITDA Guidance
February 17, 2022 6:08 AM ESTMEDNAX (NYSE: MD) reported Q4 EPS of $0.52, $0.08 better than the analyst estimate of $0.44. Revenue for the quarter came in at $499 million versus the consensus estimate of $483.83 million.
On a preliminary basis, Mednax anticipates that its 2022 Adjusted EBITDA, as defined above, will be at least $270... More
